Search research articles
Contact Us
Filters
Showing results (21-30 of 115) with videos related to
Page
of 12
Sort By:
Molecular Oncology
|
April 23, 2017
Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on-target ALK inhibitors in neuroblastoma
Elizabeth R Tucker, Jennifer R Tall, Laura S Danielson, et al.
Scientific Reports
|
December 2, 2020
<sup>18</sup>F-meta-fluorobenzylguanidine (<sup>18</sup>F-mFBG) to monitor changes in norepinephrine transporter expression in response to therapeutic intervention in neuroblastoma models
Stephen Turnock, David R Turton, Carlos Daniel Martins, et al.
Cancer Research
|
August 17, 2006
Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma
Louis Chesler, Chris Schlieve, David D Goldenberg, et al.
British Journal of Cancer
|
August 9, 2017
Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform
Gilberto S Almeida, Rafal Panek, Albert Hallsworth, et al.
Oncotarget
|
February 18, 2020
Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma
Lidia Franco-Luzón, África González-Murillo, Cristina Alcántara-Sánchez, et al.
Cancer Research
|
October 1, 2024
Editor's Note: Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma
Louis Chesler, Chris Schlieve, David D Goldenberg, et al.
Cell Genomics
|
February 15, 2024
Better translation via collaboration: The MRC National Mouse Genetics Network
Owen Sansom, Sara Wells, David Kent, et al.
JCO Precision Oncology
|
January 11, 2024
Precision Medicine for Childhood Cancer: Current Limitations and Future Perspectives
Martin G McCabe, Birgit Geoerger, Louis Chesler, et al.
Neoplasia (New York, N.Y.)
|
October 28, 2008
Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction
Louis Chesler, David D Goldenberg, Rodney Collins, et al.
Cancer Gene Therapy
|
September 15, 2021
The biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme
Zuzanna Urban-Wójciuk, Amy Graham, Karen Barker, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 115) with videos related to
Sort By:
Page
of 12
Molecular Oncology
|
April 23, 2017
Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on-target ALK inhibitors in neuroblastoma
Elizabeth R Tucker, Jennifer R Tall, Laura S Danielson, et al.
Scientific Reports
|
December 2, 2020
<sup>18</sup>F-meta-fluorobenzylguanidine (<sup>18</sup>F-mFBG) to monitor changes in norepinephrine transporter expression in response to therapeutic intervention in neuroblastoma models
Stephen Turnock, David R Turton, Carlos Daniel Martins, et al.
Cancer Research
|
August 17, 2006
Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma
Louis Chesler, Chris Schlieve, David D Goldenberg, et al.
British Journal of Cancer
|
August 9, 2017
Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform
Gilberto S Almeida, Rafal Panek, Albert Hallsworth, et al.
Oncotarget
|
February 18, 2020
Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma
Lidia Franco-Luzón, África González-Murillo, Cristina Alcántara-Sánchez, et al.
Cancer Research
|
October 1, 2024
Editor's Note: Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma
Louis Chesler, Chris Schlieve, David D Goldenberg, et al.
Cell Genomics
|
February 15, 2024
Better translation via collaboration: The MRC National Mouse Genetics Network
Owen Sansom, Sara Wells, David Kent, et al.
JCO Precision Oncology
|
January 11, 2024
Precision Medicine for Childhood Cancer: Current Limitations and Future Perspectives
Martin G McCabe, Birgit Geoerger, Louis Chesler, et al.
Neoplasia (New York, N.Y.)
|
October 28, 2008
Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction
Louis Chesler, David D Goldenberg, Rodney Collins, et al.
Cancer Gene Therapy
|
September 15, 2021
The biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme
Zuzanna Urban-Wójciuk, Amy Graham, Karen Barker, et al.
Page
of 12